AAR/AAR+HAR vs AAR+TAR+FET for Type A Aortic Intramural Hematoma

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorSecond Hospital of Jilin University

About this trial

This is a prospective, randomized, non-inferiority clinical trial designed to compare the efficacy and safety of two surgical strategies for acute type A aortic intramural hematoma (TAIMH): (1) ascending aorta replacement or ascending aorta plus hemiarch replacement (AAR/AAR+HAR), and (2) ascending aorta replacement with total arch replacement and frozen elephant trunk implantation (AAR+TAR+FET). Patients will be enrolled based on CTA confirmation of a completely thrombosed false lumen in the ascending aorta and aortic arch. Eligible participants will be randomized in a 1:1 ratio to either group. The primary endpoint is the rate of reintervention on the aortic arch or descending aorta from 6 to 12 months after surgery. Secondary endpoints include circulatory arrest time, aortic cross-clamp time, major adverse cardiovascular events, other perioperative complications, and total hospitalization cost. A total of 400 participants will be enrolled.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥ 18 years and ≤ 80 years.

Diagnosis of type A aortic intramural hematoma (TAIMH).

Ability to understand the study procedure and provide written informed consent.

Disqualifiers

Preoperative CTA shows an open or partially thrombosed (mixed) false lumen in the ascending aorta or arch.

Primary tear located on the greater curvature of the aortic arch, necessitating total arch replacement.

Planned concomitant major cardiac surgery (e.g., CABG, valve replacement, atrial fibrillation ablation).

Previous history of aortic arch or distal aortic surgery.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Ascending Aorta Replacement / Ascending Aorta Plus Hemiarch Replacement

    Procedure/Surgery

    This procedure involves ascending aorta replacement alone or ascending aorta plus hemiarch replacement, according to the operative strategy. The ascending aorta is replaced with or without replacement of the proximal aortic arch, while the distal arch and supra-aortic vessels are preserved.

  • Ascending Aorta Replacement With Total Arch Replacement and Frozen Elephant Trunk

    Procedure/Surgery

    This procedure involves ascending aorta replacement with total arch replacement and frozen elephant trunk implantation. The entire aortic arch is replaced, and a frozen elephant trunk is implanted into the proximal descending aorta.

Treatment groups

400 Participants
are divided into 2 treatment groups
Group A: AAR/AAR+HAR GroupExperimental treatment 1 intervention
Group B: AAR+TAR+FET GroupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Rate of reintervention on the aortic arch or descending aorta

The proportion of patients requiring any secondary surgical or endovascular procedure involving the aortic arch or descending aorta during follow-up after the index operation.

Time frame
6 to 12 months after surgery

Secondary outcomes

1

Aortic Cross-Clamp Time

Duration (minutes) of aortic cross-clamping during surgery.

Time frame
Intraoperative
2

Circulatory Arrest Time

Duration (minutes) of total circulatory arrest.

Time frame
Intraoperative
3

Major Adverse Cardiovascular Events (MACE)

Incidence of major adverse cardiovascular events during the perioperative period. The exact components should follow the study protocol and statistical analysis plan.

Time frame
Through 30 days after surgery
4

Other perioperative complications

Incidence of perioperative complications during the perioperative period, including but not limited to neurological events, renal dysfunction, infection, bleeding, and cardiac failure.

Time frame
Through 30 days after surgery

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: